S&P 500   3,329.35 (+0.26%)
DOW   29,228.32 (+0.11%)
QQQ   224.75 (+0.66%)
AAPL   319.24 (+0.84%)
FB   222.33 (+0.40%)
MSFT   166.50 (+0.00%)
GOOGL   1,492.31 (+0.68%)
AMZN   1,894.19 (+0.12%)
CGC   24.31 (+0.66%)
NVDA   251.98 (+1.63%)
MU   59.70 (+1.24%)
GE   11.36 (-2.57%)
TSLA   587.92 (+7.44%)
AMD   51.77 (+1.41%)
T   39.07 (+1.40%)
ACB   2.04 (+1.49%)
F   9.20 (-0.11%)
NFLX   329.47 (-2.56%)
BAC   34.30 (+0.12%)
DIS   144.00 (+0.31%)
GILD   63.10 (+0.75%)
S&P 500   3,329.35 (+0.26%)
DOW   29,228.32 (+0.11%)
QQQ   224.75 (+0.66%)
AAPL   319.24 (+0.84%)
FB   222.33 (+0.40%)
MSFT   166.50 (+0.00%)
GOOGL   1,492.31 (+0.68%)
AMZN   1,894.19 (+0.12%)
CGC   24.31 (+0.66%)
NVDA   251.98 (+1.63%)
MU   59.70 (+1.24%)
GE   11.36 (-2.57%)
TSLA   587.92 (+7.44%)
AMD   51.77 (+1.41%)
T   39.07 (+1.40%)
ACB   2.04 (+1.49%)
F   9.20 (-0.11%)
NFLX   329.47 (-2.56%)
BAC   34.30 (+0.12%)
DIS   144.00 (+0.31%)
GILD   63.10 (+0.75%)
S&P 500   3,329.35 (+0.26%)
DOW   29,228.32 (+0.11%)
QQQ   224.75 (+0.66%)
AAPL   319.24 (+0.84%)
FB   222.33 (+0.40%)
MSFT   166.50 (+0.00%)
GOOGL   1,492.31 (+0.68%)
AMZN   1,894.19 (+0.12%)
CGC   24.31 (+0.66%)
NVDA   251.98 (+1.63%)
MU   59.70 (+1.24%)
GE   11.36 (-2.57%)
TSLA   587.92 (+7.44%)
AMD   51.77 (+1.41%)
T   39.07 (+1.40%)
ACB   2.04 (+1.49%)
F   9.20 (-0.11%)
NFLX   329.47 (-2.56%)
BAC   34.30 (+0.12%)
DIS   144.00 (+0.31%)
GILD   63.10 (+0.75%)
S&P 500   3,329.35 (+0.26%)
DOW   29,228.32 (+0.11%)
QQQ   224.75 (+0.66%)
AAPL   319.24 (+0.84%)
FB   222.33 (+0.40%)
MSFT   166.50 (+0.00%)
GOOGL   1,492.31 (+0.68%)
AMZN   1,894.19 (+0.12%)
CGC   24.31 (+0.66%)
NVDA   251.98 (+1.63%)
MU   59.70 (+1.24%)
GE   11.36 (-2.57%)
TSLA   587.92 (+7.44%)
AMD   51.77 (+1.41%)
T   39.07 (+1.40%)
ACB   2.04 (+1.49%)
F   9.20 (-0.11%)
NFLX   329.47 (-2.56%)
BAC   34.30 (+0.12%)
DIS   144.00 (+0.31%)
GILD   63.10 (+0.75%)
Log in
(Ad)
If you're happy with stocks yielding you 4% or 5% a year, you don't need this. But if you want to see how we built a portfolio that now pays us a 67% cash on cash return - with no leverage, options, or gimmicks.

NYSE:HUM - Humana Stock Price, Forecast & News

$366.19
+1.32 (+0.36 %)
(As of 01/22/2020 01:10 PM ET)
Today's Range
$361.50
Now: $366.19
$366.69
50-Day Range
$341.98
MA: $361.50
$375.00
52-Week Range
$225.65
Now: $366.19
$376.39
Volume29,124 shs
Average Volume733,812 shs
Market Capitalization$48.49 billion
P/E Ratio19.46
Dividend Yield0.60%
Beta0.92
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. Read More…

Industry, Sector and Symbol

Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
CUSIP44485910
Phone502-580-1000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$56.91 billion
Cash Flow$18.78 per share
Book Value$74.95 per share

Profitability

Net Income$1.68 billion

Miscellaneous

Employees41,600
Market Cap$48.49 billion
Next Earnings Date2/5/2020 (Confirmed)
OptionableOptionable

Receive HUM News and Ratings via Email

Sign-up to receive the latest news and ratings for HUM and its competitors with MarketBeat's FREE daily newsletter.


(Ad)

In early 2019 President Trump warned this company's biggest customers to "step up their 5G efforts." A few months later, he banned their biggest competitor from doing business in the U.S. Now, this $5 stock could turn a $10,000 stake into $234,770 this year. But timing is critical. A single mention on the evening news and this opportunity could get away from you.

Humana (NYSE:HUM) Frequently Asked Questions

What is Humana's stock symbol?

Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."

How often does Humana pay dividends? What is the dividend yield for Humana?

Humana declared a quarterly dividend on Thursday, October 24th. Shareholders of record on Tuesday, December 31st will be paid a dividend of $0.55 per share on Friday, January 31st. This represents a $2.20 annualized dividend and a yield of 0.60%. The ex-dividend date is Monday, December 30th. View Humana's Dividend History.

How were Humana's earnings last quarter?

Humana Inc (NYSE:HUM) released its quarterly earnings data on Wednesday, November, 6th. The insurance provider reported $5.03 earnings per share for the quarter, beating the Zacks' consensus estimate of $4.58 by $0.45. The insurance provider earned $16.24 billion during the quarter, compared to analyst estimates of $16.15 billion. Humana had a return on equity of 22.32% and a net margin of 4.06%. Humana's revenue for the quarter was up 14.3% on a year-over-year basis. During the same period in the previous year, the firm posted $4.58 EPS. View Humana's Earnings History.

When is Humana's next earnings date?

Humana is scheduled to release their next quarterly earnings announcement on Wednesday, February 5th 2020. View Earnings Estimates for Humana.

How can I listen to Humana's earnings call?

Humana will be holding an earnings conference call on Wednesday, February 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has Humana issued on next quarter's earnings?

Humana issued an update on its FY 2019 After-Hours earnings guidance on Monday, December, 2nd. The company provided earnings per share (EPS) guidance of 17.75-17.75 for the period, compared to the Thomson Reuters consensus EPS estimate of $17.77.

What price target have analysts set for HUM?

16 Wall Street analysts have issued 12-month price objectives for Humana's shares. Their forecasts range from $290.00 to $448.00. On average, they anticipate Humana's stock price to reach $355.75 in the next twelve months. This suggests that the stock has a possible downside of 2.9%. View Analyst Price Targets for Humana.

What is the consensus analysts' recommendation for Humana?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Humana in the last year. There are currently 4 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Humana.

Has Humana been receiving favorable news coverage?

Press coverage about HUM stock has trended negative this week, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Humana earned a daily sentiment score of -2.3 on InfoTrie's scale. They also gave press coverage about the insurance provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Humana.

Are investors shorting Humana?

Humana saw a increase in short interest in the month of December. As of December 31st, there was short interest totalling 2,180,000 shares, an increase of 13.0% from the December 15th total of 1,930,000 shares. Based on an average daily volume of 957,000 shares, the short-interest ratio is presently 2.3 days. Approximately 1.7% of the shares of the company are short sold. View Humana's Current Options Chain.

Who are some of Humana's key competitors?

What other stocks do shareholders of Humana own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Humana investors own include UnitedHealth Group (UNH), NVIDIA (NVDA), Mastercard (MA), Walt Disney (DIS), Visa (V), Alibaba Group (BABA), Boeing (BA), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and salesforce.com (CRM).

Who are Humana's key executives?

Humana's management team includes the folowing people:
  • Mr. Bruce Dale Broussard, Pres, CEO & Director (Age 57)
  • Mr. Brian Andrew Kane, Chief Financial Officer (Age 46)
  • Mr. Timothy S. Huval, Chief HR Officer (Age 53)
  • Ms. Jody L. Bilney, Chief Consumer Officer (Age 58)
  • Dr. William Kevin Fleming Pharm.D., PharmD, RPh, Segment Pres of Healthcare Services (Age 51)

Who are Humana's major shareholders?

Humana's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Calamos Advisors LLC (0.17%), Artemis Investment Management LLP (0.16%), PGGM Investments (0.07%), Scout Investments Inc. (0.06%), Nisa Investment Advisors LLC (0.05%) and Rhenman & Partners Asset Management AB (0.05%). Company insiders that own Humana stock include Brian P Leclaire, Bruce D Broussard, Christopher H Hunter, Cynthia H Zipperle, David A Jr/Ky Jones, Elizabeth D Bierbower, Heidi S Margulis, James J /Ky Obrien, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming. View Institutional Ownership Trends for Humana.

Which major investors are selling Humana stock?

HUM stock was sold by a variety of institutional investors in the last quarter, including Calamos Advisors LLC, Coronation Fund Managers Ltd., Meag Munich Ergo Kapitalanlagegesellschaft MBH, Atlas Brown Inc., State of Alaska Department of Revenue, FormulaFolio Investments LLC, Stock Yards Bank & Trust Co. and B & T Capital Management DBA Alpha Capital Management. Company insiders that have sold Humana company stock in the last year include Brian P Leclaire, Christopher H Hunter, Elizabeth D Bierbower, James J /Ky Obrien, Roy A Beveridge, Timothy Alan Wheatley and Timothy S Huval. View Insider Buying and Selling for Humana.

Which major investors are buying Humana stock?

HUM stock was acquired by a variety of institutional investors in the last quarter, including PGGM Investments, Scout Investments Inc., DNB Asset Management AS, Artemis Investment Management LLP, Rhenman & Partners Asset Management AB, Commerzbank Aktiengesellschaft FI, TrimTabs Asset Management LLC and Sciencast Management LP. View Insider Buying and Selling for Humana.

How do I buy shares of Humana?

Shares of HUM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Humana's stock price today?

One share of HUM stock can currently be purchased for approximately $366.19.

How big of a company is Humana?

Humana has a market capitalization of $48.49 billion and generates $56.91 billion in revenue each year. The insurance provider earns $1.68 billion in net income (profit) each year or $14.55 on an earnings per share basis. Humana employs 41,600 workers across the globe.View Additional Information About Humana.

What is Humana's official website?

The official website for Humana is http://www.humana.com/.

How can I contact Humana?

Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider can be reached via phone at 502-580-1000 or via email at [email protected]


MarketBeat Community Rating for Humana (NYSE HUM)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  762 (Vote Outperform)
Underperform Votes:  800 (Vote Underperform)
Total Votes:  1,562
MarketBeat's community ratings are surveys of what our community members think about Humana and other stocks. Vote "Outperform" if you believe HUM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HUM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/22/2020 by MarketBeat.com Staff

Featured Article: Bond

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel